← Leaderboards
Karen E Knudsen
University Of Cincinnati
$24,017,647
Attributed
$25,744,886
Total exposure
36
Grants
36
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$47,645,990 · 37
By mechanism
P30$33,064,459 · 27
R01$14,255,240 · 8
R21$320,791 · 1
R13$5,500 · 1
Top collaborators
- Steven B Mcmahon5 shared
- William K. Kelly3 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTranslational ResearchProgramsCancer CenterMemberResearch PersonnelFundingClinical ResearchInstructionResource SharingMolecularTumorUniversitiesBaseBasic ScienceFacultyAnticancer ResearchClinical TrialsAreaMalignant Neoplasm Of ProstatePublicationsCellsServicesGrowth
Grant awards (152)
Leadership, Planning and Evaluation$400,725
P30 · FY2022 · CA · contact PI
Developmental Funds$142,559
P30 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$400,725
P30 · FY2021 · CA · contact PI
Developmental Funds$142,559
P30 · FY2021 · CA · contact PI
Strengthening Community Engagement in Colorectal Cancer Screening and Clinical Trial Enrollment Through a Community Health Educator$115,000
P30 · FY2021 · CA · contact PI
Translational Research in Cancer$2,874,240
P30 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$400,725
P30 · FY2020 · CA · contact PI
Translational Research in Cancer$391,000
P30 · FY2020 · CA · contact PI
Optimizing telehealth across the cancer care continuum during the COVID-19 national emergency$390,000
P30 · FY2020 · CA · contact PI
Translational Research in Cancer$150,000
P30 · FY2020 · CA · contact PI
Translational Research in Cancer$149,181
P30 · FY2020 · CA · contact PI
Developmental Funds$142,559
P30 · FY2020 · CA · contact PI
Translational Research in Cancer$115,000
P30 · FY2020 · CA · contact PI
Translational Research in Cancer$2,874,240
P30 · FY2019 · CA · contact PI
USP22 Function in Advanced Prostate Cancer$478,693
R01 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$400,725
P30 · FY2019 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$346,682
R01 · FY2019 · CA · contact PI
Developmental Funds$142,559
P30 · FY2019 · CA · contact PI
Translational Research in Cancer$115,000
P30 · FY2019 · CA · contact PI
Translational Research in Cancer$2,888,240
P30 · FY2018 · CA · contact PI
USP22 Function in Advanced Prostate Cancer$493,498
R01 · FY2018 · CA · contact PI
RB Function in Prostate Cancer Progression$431,269
R01 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$400,725
P30 · FY2018 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$360,198
R01 · FY2018 · CA · contact PI
Translational Research in Cancer$224,993
P30 · FY2018 · CA · contact PI
Developmental Funds$142,559
P30 · FY2018 · CA · contact PI
Developmental Funds$11,841
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$11,841
P30 · FY2018 · CA · contact PI
Translational Research in Cancer$2,807,751
P30 · FY2017 · CA · contact PI
USP22 Function in Advanced Prostate Cancer$493,498
R01 · FY2017 · CA · contact PI
RB Function in Prostate Cancer Progression$431,269
R01 · FY2017 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$367,422
R01 · FY2017 · CA · contact PI
Senior Leadership$297,061
P30 · FY2017 · CA · contact PI
Radiation Res & Translational Biology$284,555
P30 · FY2017 · CA · contact PI
Facilities$266,923
P30 · FY2017 · CA · contact PI
Translational Research$246,155
P30 · FY2017 · CA · contact PI
Biology of Breast Cancer$225,658
P30 · FY2017 · CA · contact PI
Data & Safety Monitoring$218,868
P30 · FY2017 · CA · contact PI
Biostatistics$207,981
P30 · FY2017 · CA · contact PI
Translational Research in Cancer$175,000
P30 · FY2017 · CA · contact PI
Clinical Research Management Office$134,508
P30 · FY2017 · CA · contact PI
Bioinformatics$123,120
P30 · FY2017 · CA · contact PI
Translational Research in Cancer$117,000
P30 · FY2017 · CA · contact PI
Protocol-Specific Research Support$112,342
P30 · FY2017 · CA · contact PI
Small Animal Imaging$79,882
P30 · FY2017 · CA · contact PI
X-Ray Crylatllography$78,892
P30 · FY2017 · CA · contact PI
Protocol Review and Monitoring System$75,880
P30 · FY2017 · CA · contact PI
Developmental Funds$64,174
P30 · FY2017 · CA · contact PI
Translational Research in Cancer$58,442
P30 · FY2017 · CA · contact PI
Planning and Evaluation$56,447
P30 · FY2017 · CA · contact PI
Laboratory Animal$47,450
P30 · FY2017 · CA · contact PI
Administration$46,575
P30 · FY2017 · CA · contact PI
Bioimaging$44,712
P30 · FY2017 · CA · contact PI
Flow Cytometry$41,487
P30 · FY2017 · CA · contact PI
Gastrointestinal Cancer$38,251
P30 · FY2017 · CA · contact PI
Cancer Cell Biology and Signaling$31,462
P30 · FY2017 · CA · contact PI
Molecular Biology and Genetics Program$30,887
P30 · FY2017 · CA · contact PI
Cancer Genomics$27,401
P30 · FY2017 · CA · contact PI
Biology of Prostate Cancer$27,080
P30 · FY2017 · CA · contact PI
Translational Research in Cancer$2,807,751
P30 · FY2016 · CA · contact PI
USP22 Function in Advanced Prostate Cancer$457,244
R01 · FY2016 · CA · contact PI
RB Function in Prostate Cancer Progression$431,269
R01 · FY2016 · CA · contact PI
SWI/SNF dysregulation in development and disease$321,625
R01 · FY2016 · CA · contact PI
Senior Leadership$297,061
P30 · FY2016 · CA · contact PI
Radiation Res & Translational Biology$284,555
P30 · FY2016 · CA · contact PI
Facilities$266,923
P30 · FY2016 · CA · contact PI
Translational Research$246,155
P30 · FY2016 · CA · contact PI
Biology of Breast Cancer$225,658
P30 · FY2016 · CA · contact PI
Data & Safety Monitoring$218,868
P30 · FY2016 · CA · contact PI
Biostatistics$207,981
P30 · FY2016 · CA · contact PI
Clinical Research Management Office$134,508
P30 · FY2016 · CA · contact PI
Bioinformatics$123,120
P30 · FY2016 · CA · contact PI
Translational Research in Cancer$117,000
P30 · FY2016 · CA · contact PI
Protocol-Specific Research Support$112,342
P30 · FY2016 · CA · contact PI
Small Animal Imaging$79,882
P30 · FY2016 · CA · contact PI
X-Ray Crylatllography$78,892
P30 · FY2016 · CA · contact PI
Protocol Review and Monitoring System$75,880
P30 · FY2016 · CA · contact PI
Developmental Funds$64,174
P30 · FY2016 · CA · contact PI
Planning and Evaluation$56,447
P30 · FY2016 · CA · contact PI
Laboratory Animal$47,450
P30 · FY2016 · CA · contact PI
Administration$46,575
P30 · FY2016 · CA · contact PI
Bioimaging$44,712
P30 · FY2016 · CA · contact PI
Flow Cytometry$41,487
P30 · FY2016 · CA · contact PI
Gastrointestinal Cancer$38,251
P30 · FY2016 · CA · contact PI
Cancer Cell Biology and Signaling$31,462
P30 · FY2016 · CA · contact PI
Molecular Biology and Genetics Program$30,887
P30 · FY2016 · CA · contact PI
Cancer Genomics$27,401
P30 · FY2016 · CA · contact PI
Biology of Prostate Cancer$27,080
P30 · FY2016 · CA · contact PI
Translational Research in Cancer$2,807,751
P30 · FY2015 · CA · contact PI
USP22 Function in Advanced Prostate Cancer$457,244
R01 · FY2015 · CA · contact PI
RB Function in Prostate Cancer Progression$431,269
R01 · FY2015 · CA · contact PI
SWI/SNF dysregulation in development and disease$321,625
R01 · FY2015 · CA · contact PI
Senior Leadership$297,061
P30 · FY2015 · CA · contact PI
Radiation Res & Translational Biology$284,555
P30 · FY2015 · CA · contact PI
Facilities$266,923
P30 · FY2015 · CA · contact PI
Translational Research$246,155
P30 · FY2015 · CA · contact PI
Biology of Breast Cancer$225,658
P30 · FY2015 · CA · contact PI
Data & Safety Monitoring$218,868
P30 · FY2015 · CA · contact PI
Biostatistics$207,981
P30 · FY2015 · CA · contact PI
Clinical Research Management Office$134,508
P30 · FY2015 · CA · contact PI
Bioinformatics$123,120
P30 · FY2015 · CA · contact PI
Protocol-Specific Research Support$112,342
P30 · FY2015 · CA · contact PI
Small Animal Imaging$79,882
P30 · FY2015 · CA · contact PI
X-Ray Crylatllography$78,892
P30 · FY2015 · CA · contact PI
Protocol Review and Monitoring System$75,880
P30 · FY2015 · CA · contact PI
Developmental Funds$64,174
P30 · FY2015 · CA · contact PI
Planning and Evaluation$56,447
P30 · FY2015 · CA · contact PI
Laboratory Animal$47,450
P30 · FY2015 · CA · contact PI
Administration$46,575
P30 · FY2015 · CA · contact PI
Bioimaging$44,712
P30 · FY2015 · CA · contact PI
Flow Cytometry$41,487
P30 · FY2015 · CA · contact PI
Gastrointestinal Cancer$38,251
P30 · FY2015 · CA · contact PI
Cancer Cell Biology and Signaling$31,462
P30 · FY2015 · CA · contact PI
Molecular Biology and Genetics Program$30,887
P30 · FY2015 · CA · contact PI
Cancer Genomics$27,401
P30 · FY2015 · CA · contact PI
Biology of Prostate Cancer$27,080
P30 · FY2015 · CA · contact PI
Translational Research in Cancer$2,723,515
P30 · FY2014 · CA · contact PI
RB Function in Prostate Cancer Progression$431,269
R01 · FY2014 · CA · contact PI
SWI/SNF dysregulation in development and disease$311,976
R01 · FY2014 · CA · contact PI
SWI/SNF dysregulation in development and disease$302,328
R01 · FY2013 · CA · contact PI
Cyclin D1: repercussions of AR control and alternative splicing in prostate cance$244,734
R01 · FY2013 · CA · contact PI
2013 Gordon Research Conference on Hormone-Dependent Cancers: Development and Pro$5,500
R13 · FY2013 · CA · contact PI
SWI/SNF dysregulation in development and disease$321,625
R01 · FY2012 · CA · contact PI
Cyclin D1: repercussions of AR control and alternative splicing in prostate cance$260,355
R01 · FY2012 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$362,089
R01 · FY2011 · ES · contact PI
Cyclin D1: repercussions of AR control and alternative splicing in prostate cance$260,355
R01 · FY2011 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$366,556
R01 · FY2010 · ES · contact PI
Cyclin D1: repercussions of AR control and alternative splicing in prostate cance$268,407
R01 · FY2010 · CA · contact PI
Role of BAF57 in AR control and prostate cancer growth$266,285
R01 · FY2010 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$374,471
R01 · FY2009 · ES · contact PI
Cyclin D1: repercussions of AR control and alternative splicing in prostate cance$268,407
R01 · FY2009 · CA · contact PI
Role of BAF57 in AR control and prostate cancer growth$266,285
R01 · FY2009 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$375,167
R01 · FY2008 · ES · contact PI
Role of BAF57 in AR control and prostate cancer growth$266,429
R01 · FY2008 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$356,671
R01 · FY2007 · ES · contact PI
Role of BAF57 in AR control and prostate cancer growth$260,504
R01 · FY2007 · CA · contact PI
Cyclin D1: Mechanism and Consequence of Androgen Receptor Inhibition$253,788
R01 · FY2007 · CA · contact PI
Targeting BRM as novel model of prostate hyperplasia$158,337
R21 · FY2007 · CA · contact PI
Endocrine disruptors: AR regulation and prostate cancer$24,499
R01 · FY2007 · ES · contact PI
Targeting BRM as novel model of prostate hyperplasia$14,254
R21 · FY2007 · CA · contact PI
Cyclin D1: Mechanism and Consequence of Androgen Receptor Inhibition$3,469
R01 · FY2007 · CA · contact PI
Role of BAF57 in AR control and prostate cancer growth$268,483
R01 · FY2006 · CA · contact PI
Cyclin D1: Mechanism and Consequence of AR Inhibition$262,801
R01 · FY2006 · CA · contact PI
Bis-phenol A: Signaling and Mitogenesis in the Prostate$244,311
R01 · FY2006 · CA · contact PI
Targeting BRM as novel model of prostate hyperplasia$148,200
R21 · FY2006 · CA · contact PI
Cyclin D1: Mechanism and Consequence of AR Inhibition$269,321
R01 · FY2005 · CA
Bis-phenol A: Signaling and Mitogenesis in the Prostate$250,390
R01 · FY2005 · CA
Cyclin D1: Mechanism and Consequence of AR Inhibition$269,507
R01 · FY2004 · CA
Bis-phenol A: Signaling and Mitogenesis in the Prostate$250,579
R01 · FY2004 · CA
Cyclin D1: Mechanism and Consequence of AR Inhibition$269,684
R01 · FY2003 · CA
Bis-phenol A: Signaling and Mitogenesis in the Prostate$250,759
R01 · FY2003 · CA
Bis-phenol A: Signaling and Mitogenesis in the Prostate$250,931
R01 · FY2002 · CA